Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October ...
These resources include downloadable fact sheets, glaucoma financial assistance resources, shareable social media graphics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback